Vor Biopharma Inc. · NASDAQ:VOR
BlackRock, Inc. reported a 5.70% stake in Vor Biopharma Inc. (Schedule 13G)
Event Jun 30, 2026 · Filed Jul 30, 2026
BlackRock, Inc. reported a 5.70% stake in Vor Biopharma Inc., 3,099,259 shares, as a passive investor on Jun 30, 2026. Filed Jul 30, 2026 (Schedule 13G).
- Stake
- 5.70%
- Shares
- 3,099,259
- Intent
- Passive
- What changed
- Crossed above 5%
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| BlackRock, Inc. | 5.70% | 3,099,259 |
Source
Related
- Vor Biopharma Inc.
- BlackRock, Inc.
- Vor Biopharma Inc. shareholders
- Form 4 · Ra Capital Management, L.P. · Oct 5, 2026
- Form 4 · RA Capital Healthcare Fund LP · Aug 26, 2026
- Schedule 13G/A · Venrock Healthcare Capital Partners III, L.P. · Aug 14, 2026
- Schedule 13G/A · Frazier Life Sciences Public Fund, L.P. · Aug 14, 2026
- Schedule 13G/A · Verve Capital Limited · Aug 13, 2026